EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study
- DOI
- 10.1016/j.jhep.2021.10.018
- Published
- 2022-03
- Container
- Journal of Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhep.2021.10.018,
title = {EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study},
author = {Vlad Ratziu and Mary E. Rinella and Brent A. Neuschwander-Tetri and Eric Lawitz and Douglas Denham and Zeid Kayali and Aasim Sheikh and Kris V. Kowdley and Taddese Desta and Magdy Elkhashab and Jeffery DeGrauw and Bryan Goodwin and Alaa Ahmad and Nathalie Adda},
year = {2022},
journal = {Journal of Hepatology},
doi = {10.1016/j.jhep.2021.10.018},
url = {https://doi.org/10.1016/j.jhep.2021.10.018}
}RIS
TY - JOUR TI - EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study AU - Vlad Ratziu AU - Mary E. Rinella AU - Brent A. Neuschwander-Tetri AU - Eric Lawitz AU - Douglas Denham AU - Zeid Kayali AU - Aasim Sheikh AU - Kris V. Kowdley AU - Taddese Desta AU - Magdy Elkhashab AU - Jeffery DeGrauw AU - Bryan Goodwin AU - Alaa Ahmad AU - Nathalie Adda PY - 2022 JO - Journal of Hepatology DO - 10.1016/j.jhep.2021.10.018 UR - https://doi.org/10.1016/j.jhep.2021.10.018 ER -
APA
Ratziu, V., Rinella, M. E., Neuschwander-Tetri, B. A., Lawitz, E., Denham, D., Kayali, Z., Sheikh, A., Kowdley, K. V., Desta, T., Elkhashab, M., DeGrauw, J., Goodwin, B., Ahmad, A., & Adda, N. (2022). EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2021.10.018
Source records
- crossref · retrieved 2026-09-27T12:08:47.294Z